Insights into the pathogenesis of galactosemia

Annual Review of Nutrition

Volumn 23, Issue , 2003, Pages 59-80

  Leslie, Nancy D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Galactitol; Galactonate; Galactose; Mouse model; UDP galactose

Indexed keywords

ALDEHYDE REDUCTASE; CARBOHYDRATE DERIVATIVE; CARBON DIOXIDE; GALACTITOL; GALACTOKINASE; GALACTONIC ACID; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GALACTOSE PHOSPHATE; LACTOSE; UNCLASSIFIED DRUG; URIDINE; URIDINE DIPHOSPHATE GALACTOSE; URIDINE DIPHOSPHATE GLUCOSE; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE; URIDINE TRIPHOSPHATE GLUCOSE 1 PHOSPHATE URIDYLYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARBOHYDRATE SYNTHESIS; CATARACT; ENZYME DEFICIENCY; GALACTOSEMIA; GENETIC MANIPULATION; HYPERGONADOTROPIC HYPOGONADISM; INTELLIGENCE QUOTIENT; KNOCKOUT MOUSE; LEARNING DISORDER; MOUSE; NONHUMAN; OVARY INSUFFICIENCY; OXIDATION; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GALACTOSE; GALACTOSEMIAS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; MICE; MICE, KNOCKOUT; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

ANIMALIA;

EID: 0042365182     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.23.011702.073135     Document Type: Review

References (61)

1. Abraham H, Howell R. 1969. Human hepatic uridine diphosphate galactose pyrophosphorylase. J. Biol. Chem. 244:545
2. Ai Y, Zheng Z, O'Brien-Jenkins A, Bernard DJ, Wynshaw-Boris T, et al. 2000. A mouse model of galactose-induced cataracts. Hum. Mol. Genet. 9(12):1821-27
3. Berry GT, Hunter JV, Wang Z, Dreha S, Mazur A, et al. 2001. In vivo evidence of brain galactitol accumulation in an encephalopathic infant with galactosemia. J. Pediatr. 138:260-62
4. Berry GT, Leslie N, Reynolds R, Yager CT, Segal S. 2001. Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene. Mol. Genet. Metab. 72:316-21
5. Berry GT, Nissim I, Gibson JB, Mazur AT, Lin Z, et al. 1997. Quantitative assessment of whole body galactose metabolism in galactosemic patients. Eur. J. Pediatr. 156(Suppl. 1):S43-49
6. Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, Segal S. 1995. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet 346:1073-107
7. Berry GT, Singh RH, Mazur AT, Guerrero N, Kennedy JJ, et al. 2000. Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes. Pediatr. Res. 48:323-28
8. Brenner C. 2002. Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 41:9003-13
9. Brown GK. 2000. Glucose transporters: structure, function, and consequences of deficiency. J. Inherit. Metab. Dis. 23:237-36
10. Charlwood J, Clayton P, Keir G, Mian N, Winchester B. 1998. Defective galactosylation of serum transferrin in galactosemia. Glycobiology 8:351-57
11. Chen J, Yager C, Reynolds R, Palmieri M, Segal S. 2002. Erythrocyte galactose 1-phosphate quantified by isotope-dilution gas chromatography-mass spectrometry. Clin. Chem. 48:604-12
12. Christiacos MC, Marson MJ, Wells L, Riehman K, Fridovich-Keil JL. 2000. Subcellular localization of galactose-1-phosphate uridylyltransferase in the yeast Saccharomyces cerevisiae. Mol. Genet. Metab. 70:272-80
13. Cozen W, Peters R, Reichardt JK, Ng W, Felix JC, et al. 2002. Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 13:113-20
14. Cuatrecasas P, Segal S. 1966. Galactose conversion to D-xylulose: an alternate route of galactose metabolism. Science 153:549-51
15. Cuatrecasas P, Segal S. 1966. Mammalian galactose dehydrogenase. I. Identification and purification in rat liver. J. Biol. Chem. 241:5904-9
16. Cuatrecasas P, Segal S. 1966. Mammalian galactose dehydrogenase. II. Properties substrate specificity and developmental changes. J. Biol. Chem. 241:5910-18
17. Daran JM, Bell W, Francois J. 1997. Physiological and morphological effects of genetic alterations leading to a reduced synthesis of UDP-glucose in Saccharomyces cerevisiae. FEMS Microbiol. Lett. 153(1):89-96
18. Dobbie JA, Holton JB, Clamp JR. 1990. Defective galactosylation of proteins in cultured skin fibroblasts from galactosaemic patients. Ann. Clin. Biochem. 27:274-75
19. Frey PA. 1996. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 10:461-70
20. Gibson JB, Reynolds RA, Palmieri MJ, Berry GT, Elsas LJ 2nd, et al. 1995. Comparison of erythrocyte uridine sugar nucleotide levels in normals, classic galactosemics, and patients with other metabolic disorders. Metabolism 44:597-604
21. Gitzelmann R. 1995. Galactose-1-phosphate in the pathophysiology of galactosemia. Eur. J. Pediatr. 154:S45-49
22. Heidenreich RA, Mallee J, Rogers S, Segal S. 1993. Developmental and tissue-specific modulation of rat galactose-1-phosphate uridyltransferase steady state messenger RNA and specific activity levels. Pediatr. Res. 34:416-19
23. Henderson JM, Wells L, Fridovich-Keil JL. 2000. Covalent heterogeneity of the human enzyme galactose-1-phosphate uridylyltransferase. J. Biol. Chem. 275:30088-91
24. Ho HTB, Chung SK, Law JWS, Ko BCB, Tan SCF, et al. 2000. Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol. Cell Biol. 20:5840-46
25. Holton JB, de la Cruz F, Levy HL. 1993. Galactosemia: the uridine diphosphate galactose deficiency-uridine treatment controversy. J. Pediatr 123:1009-14
26. Kaufman FR, Horton EJ, Gott P, Wolff JA, Nelson MD Jr, et al. 1995. Abnormal somatosensory evoked potentials in patients with classic galactosemia: correlation with neurologic outcome. J. Child Neurol. 10(1):32-36
27. Kaufman FR, McBride-Chang C, Manis FR, Wolff JA, Nelson MD. 1995. Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur. J. Pediatr. 154(7 Suppl. 2):S2-5
28. Kaufman FR, Xu YK, Ng WG, Silva PD, Lobo RA, Donnell GN. 1989. Gonadal function and ovarian galactose metabolism in classic galactosemia. Acta Endocrinol. (Copen.) 120(2):129-33
29. Kirkman HN. 1995. Measurements of uridine diphosphate glucose and uridine diphosphate galactose - an appraisal. Eur. J. Pediatr. 154(7 Suppl 2):S72-74
30. Kleigman RM, Sparks JW. 1985. Perinatal galactose metabolism. J. Pediatr. 107:831-41
31. Lai K, Elsas LJ. 2000. Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase-deficient yeast. Biochem. Biophys. Res. Commun. 271(2):392-400
32. Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ 2nd. 1996. A prevalent mutation for galactosemia among black Americans. J. Pediatr. 128(1):89-95
33. Leslie ND, Bai S. 2001. Functional characterization of the mouse galactose-1-phosphate uridyltransferase promoter. Mol. Genet. Metab. 72:31-38
34. Leslie ND, Yager CL, McNamara PD, Segal S. 1996. A mouse model of galactose-1-phosphate uridyltransferase deficiency. Biochem. Mol. Med. 59:7-12
35. Manis FR, Cohn LB, McBride-Chang C, Wolff JA, Kaufman FR. 1997. A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine. J. Inherit. Metab. Dis. 20:549-55
36. Nelson D. 1995. Verbal dyspraxia in children with galactosemia. Eur. J. Pediatr. 154(7 Suppl. 2):S6-7
37. Nelson MD Jr, Wolff JA, Cross CA, Donnell GN, Kaufman FR. 1992. Galactosemia: evaluation with MR imaging. Radiology 184(1):255-61
38. Ning C, Fenn PT, Blair IA, Berry GT, Segal S. 2000. Apparent galactose appearance rate in human galactosemia based on plasma [(13)C] galactose isotopic enrichment. Mol. Genet. Metab. 70:261-71
39. Ning C, Reynolds R, Chen J, Yager C, Berry GT, et al. 2001. Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet. Mol. Genet. Metab. 72:306-15
40. Ning C, Reynolds R, Chen J, Yager C, Berry GT, et al. 2000. Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr. Res. 48:211-17
41. Ning C, Segal S. 2000. Plasma galactose and galactitol concentration in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia: determination by gas chromatography/mass spectrometry. Metabolism 49:1460-66
42. Ornstein KS, McGuire EJ, Berry GT, Roth S, Segal S. 1992. Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency. Pediatr. Res. 31:508-11
43. Petty K, Greinix HT, Nudelman E, Eisen H, Hakomori S, et al. 1991. Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem. Med. Metab. Biol. 46:93-104
44. Pourci ML, Mangeot M, Soni T, Lemonnier A. 1990. Culture of galactosaemic fibroblasts in the presence of galactose: effect of inosine. J. Inherit. Metab. Dis. 13(6):819-28
45. Prestoz LL, Couto AS, Shin YS, Petry KG. 1997. Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur. J. Pediatr. 156:116-20
46. Quan-MA R, Wells HJ, Wells WW, Sherman FE, Egan TJ. 1966. Galactitol in tissues of a galactosemic child. Am. J. Dis. Child. 112:477-78
47. Segal S. 1995. Defective galactosylation in galactosemia: Is low cell UDPgalactose an explanation? Eur. J. Pediatr. 154 (7 Suppl 2):S65-71
48. Segal S. 1998. Galactosaemia today: the enigma and the challenge. J. Inherit. Metab. Dis. 21:455-71
49. 14C galactose by patients with congenital galactosemia: evidence for a direct oxidative pathway. Am. J. Med. 44:340-47
50. Segal S, Rogers S. 1990. Regulation of galactose metabolism: implications for therapy. J. Inherit. Metab. Dis. 13:487-500
51. Shin YS. 1995. Nucleotide sugars: determination of cellular levels and discrepancies in results. Eur. J. Pediatr. 154(7 Suppl 2):S75-76
52. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, et al. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc. Nat. Acad. Sci. USA 99:4465-70
53. Thoden JB, Henderson JM, Fridovich-Keil JL, Holden HM. 2002. Structural analyses of the Y229C mutant of E. coli UDP-galactose 4-epimerase. J. Biol. Chem. 277:27528-34
54. Thoden JB, Wohlers TM, Fridovich-Keil JL, Holden HM. 2001. Human UDP-galactose 4-epimerase accommodation of UDP-N-acetylglucosamine within the active site. J. Biol. Chem. 276:15131-36
55. Vilotte JL. 2002. Lowering the milk lactose content in vivo: potential interests, strategies, and physiological consequences. Reprod. Nutr. Dev. 42:127-32
56. Walter JH, Roberts REP, Besley GTN, Wraith JE, Cleary MA, et al. 1999. Generalised uridine diphosphate galactose-4-epimerase deficiency. Arch. Dis. Child. 80:374-76
57. Wang ZI, Berry GT, Dreha SF, Zhao H, Segal S, Zimmerman RA. 2001. Proton magnetic resonance spectroscopy of brain metabolites in galactosemia. Ann. Neurol. 50:266-69
58. Wehrli S, Berry GT, Palmieri MJ, Mazur A, Elsas LJ, Segal S. 1997. Urinary galactonate in patients with galactosemia: quantitation by NMR spectroscopy. Pediatr. Res. 42:855-61
59. Wells W, Pittman T, Wells H, Egan TJ. 1965. The isolation and identification of galactitol from the brains of galactosemic patients. J. Biol. Chem. 240:1002-3
60. Wohlers TM, Christiacos NC, Harreman MT, Fridovich-Keil JL. 1999. Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia. Am. J. Hum. Genet. 64:462-70
61. Yabe-Nishimura C. 1998. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50:21-34